Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2005
12/06/2005CA2354606C Azabicycloalkane derivatives and therapeutic uses thereof
12/06/2005CA2349338C Novel macrolide antibiotics
12/06/2005CA2347512C Adenine derivatives
12/06/2005CA2303244C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
12/06/2005CA2268866C Substituted arylalkylamines as neurokinin antagonists
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/01/2005WO2005113603A1 Eradication of helicobacter infection by activation of stomach mast cells
12/01/2005WO2005112881A1 The dispersible montmorillonite tablet and its preparation technology
12/01/2005US20050267205 2,4-dihydroxybenzoic acid derivatives
12/01/2005US20050267201 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/01/2005US20050267196 Reducing tumor necrosis factor; phosphodiesterase inhibitor; anticancer agents; antidepressants; antiinflammatory agents; skin dsorders; antidepressants
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267189 Celecoxib compositions
12/01/2005US20050267186 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/01/2005US20050267183 Selective estrogen receptor modulators
12/01/2005US20050267165 Il-8 receptor antagonists
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267153 Administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, mixtures thereof, or immunomodulating/immunostimulating agents; inhibiting replication and secretion, reduced toxicity
12/01/2005US20050267129 Dipeptide nitrile cathepsin K inhibitors
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient
12/01/2005US20050267111 Pharmaceutical compositions and methods for use
12/01/2005US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization
12/01/2005US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides
12/01/2005US20050267044 Novel compounds and compositions as cathepsin S inhibitors
12/01/2005US20050267042 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine
12/01/2005US20050267038 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266108 Methods of purifying cannabinoids from plant material
12/01/2005US20050266075 Omeprazole dosage form
12/01/2005US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies
12/01/2005US20050265976 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
12/01/2005US20050265932 Collagenolytic active enzyme containing compositions, and their use in the dental field
12/01/2005DE102004022383A1 New pyridopyrazine derivatives are modulators of kinase activity, useful for the treatment of diseases associated with abnormal cellular signaling, e.g. tumors
12/01/2005CA2776682A1 Tiacumicin b compound
12/01/2005CA2469427A1 Dry mixed dosage form containing benzimidazole derivatives
11/2005
11/30/2005EP1600440A1 Indole derivative compounds and drugs containing the compounds as the active ingredient
11/30/2005EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle
11/30/2005EP1600141A1 Collagenolytic active enzyme containing compositions, and their use in the dental field
11/30/2005EP1599482A1 Pyrazolo 1,5-a pyrimidine derivatives
11/30/2005EP1599481A1 6-substituted imidazopyrazines
11/30/2005EP1599175A2 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
11/30/2005EP1458381B1 Triazoles as oxytocin antagonists
11/30/2005EP1313740B1 Prodrugs of imidazopyridine derivatives
11/30/2005EP1313697B1 Immunoregulatory compounds, derivatives thereof and their use
11/30/2005EP1289534B1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/30/2005EP1221941A4 Powder pharmaceutical formulations
11/30/2005EP1178740B1 Sports drink comprising micronutrients and viable lactobacilli
11/30/2005EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
11/30/2005EP0920424B1 Non-peptide bombesin receptor antagonists
11/30/2005CN1703197A Injectable depot compositions and uses thereof
11/30/2005CN1701815A Anti-caries oral compositions
11/30/2005CN1229390C Peptides that lower blood glucose levels
11/30/2005CN1229388C N-terminal modified protein compositions and methods therefor
11/30/2005CN1229381C Macrolides compound
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229373C Piperidinee derivatives as neurokinin1 antagonists
11/30/2005CN1229353C Method and compositions utilizing quinazolinones
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229349C Pyridine-3-carboxylic acid derivative
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229341C Method for oxidizing thioether group into sulfoxide group
11/30/2005CN1229335C Nervinolin derivatives
11/30/2005CN1229334C Inhibitors of alpha4 mediated cell adhesion
11/30/2005CN1229142C NSAID and EFGR kinase inhibitor contg. compsn. for treatment or inhibition of colonic polyps and colorectal cancer
11/30/2005CN1229140C Targeted anticarious DNA vaccine and peparation thereof
11/30/2005CN1229137C New therapeutic uses of SMR1 peptides
11/30/2005CN1229133C Medicine for treating virus hepatitis and its preparing method
11/30/2005CN1229131C Medicine for treating kidney yang deficiency and preparing method thereof
11/30/2005CN1229130C Medicine for treating kidney and spleen and preparing method thereof
11/30/2005CN1229128C Detoxification tea of white bamboo
11/30/2005CN1229124C Medicine for treating fatty liver
11/30/2005CN1229113C A Pharmaceutical composition for the treatment of autoimmune diseases
11/30/2005CN1229112C Rapid onset preparation
11/29/2005US6969729 An indole or benz(g)indole-2,3-dione-3-oxime compounds; therapeutic treatment of respiratory disorders, urogenital disorders, cardiovascular disorders, brain and psychological disorders, gastrointestinal disorders
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969724 Compounds
11/29/2005US6969719 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969511 Synthetic bulk laxative
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/29/2005CA2251430C Omeprazole formulation
11/24/2005WO2005111001A1 Novel fused heterocycles and uses thereof
11/24/2005WO2005110488A1 Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same
11/24/2005WO2005110347A1 Composition, compising hydrofluoric acid, for inhibiting dental erosion
11/24/2005US20050261629 Method for delivery of therapeutic and/or diagnostic agents
11/24/2005US20050261502 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261375 Method for providing a cathartic effect
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261338 Beta2-adrenergic receptor agonists
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261285 Tetrahydropyran derivatives and their use as therapeutic agents
11/24/2005US20050261281 Pharmaceutical compounds
1 ... 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 ... 1258